Standout Papers

Diagnosis and Management... 2014 2026 2018 2022 1.2k
  1. Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline (2023)
    Jonathan Coleman, Peter E. Clark et al. The Journal of Urology
  2. Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy (2014)
    Woonyoung Choi, Sima P. Porten et al. Cancer Cell
  3. LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC) (2023)
    Thomas Powles, Begoña P. Valderrama et al. Annals of Oncology

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

The hallmarks of cancer immune evasion
2024 Standout
Cancer therapy with antibodies
2024 Standout

Works of Jean Hoffman‐Censits being referenced

LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)
2023 Standout
The JAVELIN Bladder Medley Trial: Avelumab-Based Combinations as First-Line Maintenance in Advanced Urothelial Carcinoma
2023

Author Peers

Author Last Decade Papers Cites
Jean Hoffman‐Censits 2302 1179 886 151 3.2k
Fadi Brimo 1405 777 1318 145 3.2k
Tilman Todenhöfer 1274 900 810 168 2.6k
Richard Cathomas 1873 1394 1244 145 3.8k
G. Pignot 1373 513 951 162 2.5k
Michiel S. van der Heijden 1579 1441 617 126 3.3k
Joost L. Boormans 1449 560 813 125 2.3k
Charles C. Guo 2591 852 1657 130 4.7k
Amir Sherif 3251 1014 729 102 4.0k
Lisa Sengeløv 2085 1414 1033 45 3.4k
Arjun Vasant Balar 2960 2615 892 144 4.4k

All Works

Loading papers...

Rankless by CCL
2026